# Sports Entertainment Gaming Global Corp: financial statements, quarterly

SEGG · Nasdaq · CIK 1673481 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/segg.md) · [Financials](/companies/segg/financials.md) · [Filings](/companies/segg/filings.md) · [Insiders](/companies/segg/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/segg/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [0.7](/filings/0001493152-24-034744.md) | [0.3](/filings/0001493152-24-050194.md) | [5.5 d](/filings/0001641172-25-005663.md) | [0.3](/filings/0001493152-25-018121.md) | [0.3](/filings/0001641172-25-024882.md) | [0.2](/filings/0001493152-25-024384.md) | [0.2 d](/filings/0001493152-26-032786.md) | [0.2](/filings/0001493152-26-046279.md) | [0.2](/filings/0001641172-25-024882.md) | [0.1](/filings/0001493152-25-024384.md) | [0.0 d](/filings/0001493152-26-032786.md) | [1.2](/filings/0001493152-26-046279.md) |
| Cost of revenue | $m | [0.1](/filings/0001493152-24-034744.md) | [0.1](/filings/0001493152-24-050194.md) | [5.5 d](/filings/0001641172-25-005663.md) | [0.1](/filings/0001493152-25-018121.md) | [0.0](/filings/0001641172-25-024882.md) | [0.1](/filings/0001493152-25-024384.md) | [0.1 d](/filings/0001493152-26-032786.md) | [0.2](/filings/0001493152-26-046279.md) | [0.2](/filings/0001641172-25-024882.md) | [0.2](/filings/0001493152-25-024384.md) | [0.2 d](/filings/0001493152-26-032786.md) | [0.9](/filings/0001493152-26-046279.md) |
| Gross profit | $m | [0.6](/filings/0001493152-24-034744.md) | [0.2](/filings/0001493152-24-050194.md) | [(0.0) d](/filings/0001641172-25-005663.md) | [0.2](/filings/0001493152-25-018121.md) | [0.2](/filings/0001641172-25-024882.md) | [0.1](/filings/0001493152-25-024384.md) | [0.1 d](/filings/0001493152-26-032786.md) | [0.1](/filings/0001493152-26-046279.md) | [0.0](/filings/0001641172-25-024882.md) | [(0.1)](/filings/0001493152-25-024384.md) | [(0.2) d](/filings/0001493152-26-032786.md) | [0.3](/filings/0001493152-26-046279.md) |
| Operating income | $m | [(4.2)](/filings/0001493152-24-034744.md) | [(3.2)](/filings/0001493152-24-050194.md) | [(15.1) d](/filings/0001493152-25-018121.md) | [(5.6)](/filings/0001493152-25-018121.md) | [(5.9)](/filings/0001641172-25-024882.md) | [(3.7)](/filings/0001493152-25-024384.md) | [(3.1) d](/filings/0001493152-26-032786.md) | [(3.3)](/filings/0001493152-26-046279.md) | [(3.9)](/filings/0001641172-25-024882.md) | [(4.6)](/filings/0001493152-25-024384.md) | [(5.9) d](/filings/0001493152-26-032786.md) | [(5.2)](/filings/0001493152-26-046279.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.1](/filings/0001493152-26-046279.md) | not reported | not reported | not reported | [0.4](/filings/0001493152-26-046279.md) |
| Income tax | $m | not reported | not reported | not reported | [0.0](/filings/0001493152-25-018121.md) | [0.0](/filings/0001641172-25-024882.md) | [0.0](/filings/0001493152-25-024384.md) | [0.0 d](/filings/0001493152-26-032786.md) | [0.0](/filings/0001493152-26-046279.md) | [0.0](/filings/0001641172-25-024882.md) | [0.0](/filings/0001493152-25-024384.md) | [0.0 d](/filings/0001493152-26-032786.md) | not reported |
| Net income | $m | [(4.2)](/filings/0001493152-24-033169.md) | [(3.4)](/filings/0001493152-24-050194.md) | [(14.7) d](/filings/0001641172-25-005663.md) | [(5.6)](/filings/0001493152-25-018121.md) | [(5.9)](/filings/0001641172-25-024882.md) | [(7.9)](/filings/0001493152-25-024384.md) | [(8.8) d](/filings/0001493152-26-032786.md) | [(3.2)](/filings/0001493152-26-046279.md) | [(3.9)](/filings/0001641172-25-024882.md) | [(4.4)](/filings/0001493152-25-024384.md) | [(8.6) d](/filings/0001493152-26-032786.md) | [(4.7)](/filings/0001493152-26-046279.md) |
| Diluted EPS | $ per share | [(1.67)](/filings/0001493152-24-034744.md) | [(1.33)](/filings/0001493152-24-050194.md) | not reported | [(1.40)](/filings/0001493152-25-018121.md) | [(1.12)](/filings/0001641172-25-024882.md) | [(7.86)](/filings/0001493152-25-024384.md) | not reported | [(9.42)](/filings/0001493152-26-046279.md) | [(0.13)](/filings/0001641172-25-024882.md) | [(1.19)](/filings/0001493152-25-024384.md) | not reported | [(2.49)](/filings/0001493152-26-046279.md) |
| Basic EPS | $ per share | [(1.67)](/filings/0001493152-24-034744.md) | [(1.33)](/filings/0001493152-24-050194.md) | not reported | [(1.40)](/filings/0001493152-25-018121.md) | [(1.12)](/filings/0001641172-25-024882.md) | [(7.86)](/filings/0001493152-25-024384.md) | not reported | [(9.42)](/filings/0001493152-26-046279.md) | [(0.13)](/filings/0001641172-25-024882.md) | [(1.19)](/filings/0001493152-25-024384.md) | not reported | [(2.49)](/filings/0001493152-26-046279.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.1](/filings/0001493152-23-029753.md) | [0.1](/filings/0001493152-24-034347.md) | [0.4](/filings/0001641172-25-005663.md) | [0.1](/filings/0001493152-24-022868.md) | [0.0](/filings/0001493152-24-034744.md) | [0.1](/filings/0001493152-24-050194.md) | [0.1](/filings/0001493152-26-032786.md) | [0.5](/filings/0001493152-25-018121.md) | [0.3](/filings/0001641172-25-024882.md) | [0.3](/filings/0001493152-25-024384.md) | [0.2](/filings/0001493152-26-046279.md) | [0.8](/filings/0001493152-26-046279.md) |
| Current assets | $m | [20.4](/filings/0001493152-23-029753.md) | [20.2](/filings/0001493152-24-034347.md) | [20.3](/filings/0001641172-25-005663.md) | [20.3](/filings/0001493152-24-022868.md) | [20.5](/filings/0001493152-24-034744.md) | [20.5](/filings/0001493152-24-050194.md) | [15.9](/filings/0001493152-26-032786.md) | [16.5](/filings/0001493152-25-018121.md) | [17.2](/filings/0001641172-25-024882.md) | [18.7](/filings/0001493152-25-024384.md) | [12.9](/filings/0001493152-26-046279.md) | [14.5](/filings/0001493152-26-046279.md) |
| Total assets | $m | [76.4](/filings/0001493152-23-029753.md) | [74.8](/filings/0001493152-24-034347.md) | [64.4](/filings/0001641172-25-005663.md) | [63.1](/filings/0001493152-24-022868.md) | [62.1](/filings/0001493152-24-034744.md) | [58.4](/filings/0001493152-24-050194.md) | [52.9](/filings/0001493152-26-032786.md) | [53.4](/filings/0001493152-25-018121.md) | [53.1](/filings/0001641172-25-024882.md) | [73.4](/filings/0001493152-25-024384.md) | [52.9](/filings/0001493152-26-046279.md) | [122](/filings/0001493152-26-046279.md) |
| Current liabilities | $m | [21.6](/filings/0001493152-23-029753.md) | [23.2](/filings/0001493152-24-034347.md) | [27.8](/filings/0001641172-25-005663.md) | [28.4](/filings/0001493152-24-022868.md) | [29.4](/filings/0001493152-24-034744.md) | [30.7](/filings/0001493152-24-050194.md) | [30.4](/filings/0001493152-26-032786.md) | [31.5](/filings/0001493152-25-018121.md) | [32.4](/filings/0001641172-25-024882.md) | [29.9](/filings/0001493152-25-024384.md) | [31.9](/filings/0001493152-26-046279.md) | [54.1](/filings/0001493152-26-046279.md) |
| Total liabilities | $m | [21.6](/filings/0001493152-23-029753.md) | [23.2](/filings/0001493152-24-034347.md) | [27.8](/filings/0001641172-25-005663.md) | [28.4](/filings/0001493152-24-022868.md) | [29.4](/filings/0001493152-24-034744.md) | [30.7](/filings/0001493152-24-050194.md) | [30.4](/filings/0001493152-26-032786.md) | [31.5](/filings/0001493152-25-018121.md) | [32.4](/filings/0001641172-25-024882.md) | [29.9](/filings/0001493152-25-024384.md) | [31.9](/filings/0001493152-26-046279.md) | [54.1](/filings/0001493152-26-046279.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [52.5](/filings/0001493152-23-029753.md) | [49.5](/filings/0001493152-24-034347.md) | [34.5](/filings/0001641172-25-005663.md) | [32.5](/filings/0001493152-24-022868.md) | [30.7](/filings/0001493152-24-034744.md) | [25.7](/filings/0001493152-24-050194.md) | [20.5](/filings/0001493152-26-032786.md) | [19.9](/filings/0001493152-25-018121.md) | [19.8](/filings/0001641172-25-024882.md) | [32.9](/filings/0001493152-25-024384.md) | [20.8](/filings/0001493152-26-046279.md) | [43.3](/filings/0001493152-26-046279.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [392 d](/filings/0001493152-24-034744.md) | [(191) d](/filings/0001493152-24-050194.md) | [(1,343) d](/filings/0001641172-25-005663.md) | [(1,078)](/filings/0001493152-25-018121.md) | [(368) d](/filings/0001641172-25-024882.md) | [2,399 d](/filings/0001493152-25-024384.md) | [(2,833) d](/filings/0001493152-26-032786.md) | [(575)](/filings/0001493152-26-046279.md) | [(1,668) d](/filings/0001641172-25-024882.md) | [(4,149) d](/filings/0001493152-25-024384.md) | [2,961 d](/filings/0001493152-26-032786.md) | [(8,265)](/filings/0001493152-26-046279.md) |
| Capital expenditure | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported

## Shares

| Line item | Unit | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | period not labelled (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [2.5](/filings/0001493152-23-029753.md) | [2.5](/filings/0001493152-24-034347.md) | [2.5](/filings/0001493152-24-022868.md) | [2.5](/filings/0001493152-24-034744.md) | [2.5](/filings/0001493152-24-050194.md) | [4.0](/filings/0001493152-25-018121.md) | [5.2](/filings/0001641172-25-024882.md) | [1.0](/filings/0001493152-25-024384.md) | [0.3](/filings/0001493152-26-046279.md) | [29.0](/filings/0001641172-25-024882.md) | [3.7](/filings/0001493152-25-024384.md) | [1.9](/filings/0001493152-26-046279.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 3,413,024 at 2026-09-30, from the cover of the [10-Q filed 2026-10-08](/filings/0001493152-26-046279.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. No prices; not investment advice.